# FDA Inspection 865613 - Saving Sight - February 19, 2014

Source: https://www.keypedia.com/records/fda_inspections/saving-sight/c8b244a1-2d21-4810-ab06-e0db384b878b
Source feed: FDA_Inspections

> FDA Inspection 865613 for Saving Sight on February 19, 2014. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 865613
- Company Name: Saving Sight
- Inspection Date: 2014-02-19
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1308808 - 2026-02-25](https://www.keypedia.com/records/fda_inspections/saving-sight/972b5639-6ce4-45c0-878d-608cb2d8430b)
- [FDA Inspection 1308808 - 2026-02-25](https://www.keypedia.com/records/fda_inspections/saving-sight/4c8cc911-653e-4fef-81e7-c87a966b9611)
- [FDA Inspection 1067121 - 2018-09-19](https://www.keypedia.com/records/fda_inspections/saving-sight/715afda5-e07c-400a-81ac-76c0a09b20e2)
- [FDA Inspection 1067121 - 2018-09-19](https://www.keypedia.com/records/fda_inspections/saving-sight/152bb164-4aee-4c32-97a5-1fff6e04d99e)
- [FDA Inspection 971525 - 2016-04-21](https://www.keypedia.com/records/fda_inspections/saving-sight/492c6518-fd1e-4c15-8f71-5b8018abc5e5)

Company: https://www.keypedia.com/companies/saving-sight/9fa3ef95-6abd-4c20-a5d3-74b7f2b58ae7

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d